CAS 1713265-25-8

L-Ascorbic Acid 2-Phosphate Sesquimagnesium Salt Hydrate

CAS: 113170-55-1, 1713265-25-8

Formel: C₁₂H₁₂Mg₃O₁₈P₂·xH₂O

Reinheit: >98.0%(HPLC)

Farbe und Form: White to Light yellow to Light orange powder to crystal

Molekulargewicht: 579.07 (as Anhydrous)

Ref: 3B-A2521

L-Ascorbic Acid 2-Phosphate Sesquimagnesium Salt Hydrate (~15% Inorganics)

CAS: 1713265-25-8

Formel: C₁₂H₂₀Mg₃O₁₉P₂

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 603.1383

Ref: IN-DA01JJT2

L-Ascorbic Acid 2-Phosphate Sesquimagnesium Salt Hydrate

CAS: 1713265-25-8

L-Ascorbic Acid 2-Phosphate Sesquimagnesium Salt Hydrate

Reinheit: 98%

Ref: 54-IN13099

L-Ascorbic Acid 2-Phosphate Sesquimagnesium Salt Hydrate (~15% Inorganics)

Kontrolliertes Produkt

CAS: 1713265-25-8

Formel: C₆H₇MgO₉P

Farbe und Form: White To Off-White

Molekulargewicht: 278.39

Ref: TR-A785010

L-Ascorbic acid 2-phosphate sesquimagnesium salt hydrate

CAS: 1713265-25-8

L-Ascorbic acid 2-phosphate sesquimagnesium salt hydrate is a vitamin that has been shown to have potent transcriptional and growth factor activities. It is used in clinical practice for the treatment of diseases such as hepatitis, osteoporosis, and cancer. L-Ascorbic acid 2-phosphate sesquimagnesium salt hydrate has been shown to stimulate hepatocyte-like cells to express markers of liver function. This compound can also inhibit p450 activity in vitro and in vivo, which may be responsible for its anti-cancer properties. It promotes the transcriptional activity of human polymerase chain reaction by binding with lysine residues on the DNA template strand and stabilizing the polymerase enzyme. L-Ascorbic acid 2-phosphate sesquimagnesium salt hydrate also induces morphological changes in cultured cells, leading to cell death.

Formel: C₁₂H₁₂Mg₃O₁₈P₂·xH₂O

Reinheit: (Hplc) Min. 98.50%

Farbe und Form: White Slightly Yellow Powder

Molekulargewicht: 579.07 g/mol

Ref: 3D-FA76231

L-Ascorbic acid 2-phosphate (magnesium hydrate)

CAS: 1713265-25-8

Reinheit: 98%

Ref: 10-F554991